Isodiol International Inc. Announces North 6th Agency as PR and Social Media Agency of Record

Isodiol International Inc. (CSE:ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products announces that it is proud to name North 6^th Agency (N6A), an award-winning brand communications agency based in New York and Toronto, the Company’s PR agency of record (AOR).
Core services in the engagement include: United States, Canadian and International market media relations; PR content, writing and editorial support; strategic communications and messaging development; PR measurement and data reporting; event and tradeshow support; social media strategy, channel management, and content development.
Marcos Agramont, CEO of Isodiol, says “N6A’s energy, passion and work ethic is a great match for our company and leadership team, all of whom are driven by a common goal to bring the highest quality bioactive phytoceutical products to consumers across the world. We needed to find a partner that had a world-class reputation to spread the word of our mission to the masses, and we believe we have found that in N6A.”
Matt Rizetta, CEO of N6A, says “Isodiol has an incredibly powerful, meaningful and revolutionary story that underscores the health and wellness benefits of proper-hemp based products created by the best and brightest in the industry. The message behind their story is unprecedented in the cannabis pharma space, and we look forward to communicating to a range of targeted audiences across the mainstream, investor and speciality trade media communities in the United States, Canada, and abroad.”
For more information on N6A please visit www.n6a.com, or www.competeandcare.com to learn more about N6A’s “Compete and Care” culture and perks programs.
About Isodiol International Inc.
Isodiol International Inc. is the market leader in pharmaceutical and nutraceutical grade phytochemical compounds and the industry leader in the manufacturing and development of phytoceutical consumer products.
Isodiol is the pioneer of many firsts for the cannabis industry including commercialization of a 99%+ pure pharmaceutical grade cannabinoid crystalline isolate derived from exempt parts of the hemp plant, micro-encapsulations, and nanotechnology for the highest quality consumable and topical skin care products.
Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its phytoceutical portfolio and will aggressively continue international expansion into Latin America, Asia and Europe.
About North 6^th Agency, INC:
North 6^th Agency, Inc. (N6A) is an award-winning brand communications and social media agency based in the heart of SoHo in New York City and Toronto’s financial district.
N6A’s client roster includes emerging, mid-sized and enterprise brands from more than 30 industries. N6A has been awarded several prestigious industry recognitions, including ranking in the Top 50 in more industry categories than any agency in the United States, the #1 Fastest-Growing Firm ranking in O’Dwyer’s in 2016, NY Observer Power Agency List, Digiday “Most Innovative Culture” Award finalist, and has been selected as one of the “coolest spaces at the hottest PR firms” by the New York Observer.
N6A’s “Compete and Care” culture and “Embrace the Pace” atmosphere have been lauded as one of the most rewarding, collaborative and unique to the agency world by Forbes, Monster.com, New York Post, Chief Learning Office Magazine, Entrepreneur, and others.
For more information on N6A please visit www.n6a.com, or www.competeandcare.com to learn more about N6A’s “Compete and Care” culture and perks programs.
ON BEHALF OF THE BOARD
“Marcos Agramont” CEO & Director
COMPANY MEDIA:
www.isodiol.com
Isodiol.com
CBDnaturals.com
Iso-sport.com
CBDskincream.com
Potocoffee.coffee
ir@isodiol.com
Join Us On Facebook: https://www.facebook.com/Isodiol/
Twitter: @isodiol
Forward-Looking Information: This news release contains “forward-looking information” within the meaning of applicable securities laws relating to statements regarding the Company’s business, products and future the Company’s business, its product offerings and plans for sales and marketing. Although the Company believes that the expectations reflected in the forward looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned to not place undue reliance on forward-looking information. Such forward looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company’s products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation, and does not intend, to update any forward looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.
The CSE has not reviewed, approved or disapproved the content of this press release.
Click here to connect with Isodiol International Inc. (CSE: ISOL) to receive an Investor Presentation.